How to Buy Regulus Therapeutics Stock
Regulus Therapeutics Inc
Regulus Therapeutics Inc. , a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States.
Regulus Therapeutics stock last closed at $2.42, up 6.61% from the previous day, and has increased 79.26% in one year. It has overperformed other stocks in the Biotechnology industry by 1.01 percentage points. Regulus Therapeutics stock is currently +124.07% from its 52-week low of $1.08, and -36.15% from its 52-week high of $3.79.
As of Apr 26, 2024, there are 65.47M shares of RGLS outstanding. The market capitalization of RGLS is $158.43M. In the past 24 hours, 204,765 RGLS shares were traded.
How to Buy Regulus Therapeutics Stock
Not sure how to invest in Regulus Therapeutics stock? Here's how.
- Decide where to buy Regulus Therapeutics stock: You need to choose an online brokerage, but don't worry - we've researched dozens of online stock brokerages and apps to help you decide where to buy Regulus Therapeutics stock.
- Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Deposit money your brokerage account: Select your payment method and add your details.
- Research Regulus Therapeutics stock: The Regulus Therapeutics ticker symbol is RGLS. Is Regulus Therapeutics stock a good investment? Should you buy shares of RGLS? How do RGLS's underlying business fundamentals look? Do top analysts think Regulus Therapeutics is a good buy? Why has RGLS's stock price moved recently? (Hint: Our stock market research website can help you evaluate if RGLS is a good stock to buy).
- Place your RGLS purchase: Decide if you will purchase RGLS shares at the current market price or use a limit order to buy RGLS stock at a specific price.
- Keep tabs on your investment in RGLS: Create a watchlist to get the latest news on your new investment in Regulus Therapeutics shares.
Step 1: Decide where to buy Regulus Therapeutics stock
You will need an online brokerage account to access the NASDAQ market and buy RGLS stock.
Our preferred brokerage: eToro
In our opinion, eToro is the best brokerage. eToro gives you:
- Invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to world financial markets: From Technology to Industrials, New York to Tokyo — you can fill your portfolio with stocks from the world's top exchanges.
- Social investing: eToro offers a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by signing up for an account with eToro today.
Open eToro AccountStep 2: Create a brokerage account
Now that you've picked the best brokerage, the next step is to fill out some personal info so you can invest in RGLS today.
How to Start a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal info to open a new brokerage account.
- Submit your information by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit money your brokerage account
Now that you have filled out your info on one of the best stock market apps, you need to deposit funds:
Watch the walkthrough below if you need help transferring money into your brokerage account.
Step 4: Research Regulus Therapeutics stock
Once you have decided on the best place to buy Regulus Therapeutics stock, it's absolutely critical to analyze their stock prior to buying, so you can understand the risk and opportunity.
Regulus Therapeutics Metrics
RGLS Overview
WallStreetZen was built to help part-time investors do more accurate fundamental analysis in less time.
You can see all of the due diligence checks on RGLS's stock page.
Is RGLS stock undervalued or overvalued?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge RGLS's true value.
Using relative valuations measures:
- RGLS could be overvalued based on its P/B ratio of 7.48x, relative to Biotechnology industry P/B ratio of 5.85x
You can do more valuation analysis on RGLS's stock here.
RGLS Financial Health
Passed Financial Due Diligence Checks:
- Total RGLS debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than short-term liabilities on the RGLS balance sheet.
- There are more short-term assets than long-term liabilities on the RGLS balance sheet.
Failed Financial Due Diligence Checks:
- RGLS has $23.83M in cash and short term investments. This is not enough to cover its annual cash burn of $27.38M.
- RGLS has a relatively high debt to equity ratio of 0.45.
- RGLS has cash burn of 27378000. It does not have enough cash and short-term investments to cover this.
Do analysts think it's a good time to buy Regulus Therapeutics stock
Out of 4 sell side analysts who give recommendations on RGLS, the consensus analyst rating on Regulus Therapeutics is a Buy
Please keep in mind that analyst forecasts are not stock recommendations, nor are they investment advice.
You can dive deeper into what analysts are projecting on the Regulus Therapeutics stock forecast page.
Metrics for Advanced RGLS Traders
RGLS Growth Metrics
Last year, RGLS revenue was $0.00. During the past 5 year, RGLS's revenue has gone up by -100% per year. This was slower than the Biotechnology industry average of 28.56%.
Learn more about RGLS's earnings and revenue performance here.
Who is buying/selling RGLS?
In the last year, insiders at RGLS have bought more shares than they have sold.
Stelios Papadopoulos, Director of RGLS, was the latest RGLS insider to buy. They bought $400,000.00 worth of RGLS shares on Mar 14, 2024.
Learn more about who owns RGLS stock here.
Does RGLS provide a stable income stream?
No, Regulus Therapeutics doesn't provide an income stream by paying out dividends.
What do other investors have to say about RGLS?
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Place your RGLS purchase
There are two primary options:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are generally sufficient. - Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at a specific price limit, use a limit order.
Press the Open button and your broker will place your order.
If you need additional help with investing in stocks on eToro, watch the helpful video below:
Step 6: Keep tabs on your investment in RGLS
Now that you own some shares in RGLS, you'll want to stay up-to-date on your company.
Make a watchlist to get alerted to the latest events about your RGLS stock.
RGLS Feed
How to Buy Stock in Regulus Therapeutics
To summarize, here are the 6 steps you need to take to buy Regulus Therapeutics stock right now:
- Decide where to buy Regulus Therapeutics stock
- Create a brokerage account
- Deposit money your brokerage account
- Research Regulus Therapeutics stock
- Place your RGLS purchase
- Keep tabs on your investment in RGLS
If you need a brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to keep an eye on your new investment in Regulus Therapeutics, create your watchlist below.
More Content You May Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.